Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 16 studies | 31% ± 10% | |
lung | 12 studies | 33% ± 13% | |
kidney | 7 studies | 28% ± 13% | |
intestine | 7 studies | 34% ± 18% | |
brain | 7 studies | 26% ± 7% | |
lymph node | 5 studies | 33% ± 9% | |
liver | 5 studies | 29% ± 18% | |
pancreas | 4 studies | 45% ± 24% | |
bone marrow | 4 studies | 33% ± 11% | |
eye | 4 studies | 26% ± 8% | |
uterus | 4 studies | 32% ± 18% | |
breast | 4 studies | 19% ± 1% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 16074.82 | 459 / 459 | 100% | 132.70 | 1118 / 1118 |
esophagus | 100% | 14133.34 | 1445 / 1445 | 100% | 115.08 | 183 / 183 |
intestine | 100% | 14753.56 | 966 / 966 | 100% | 123.97 | 527 / 527 |
ovary | 100% | 23670.94 | 180 / 180 | 100% | 118.99 | 430 / 430 |
prostate | 100% | 15073.14 | 245 / 245 | 100% | 125.08 | 502 / 502 |
stomach | 100% | 12896.62 | 359 / 359 | 100% | 118.57 | 286 / 286 |
lung | 100% | 16400.39 | 578 / 578 | 100% | 117.47 | 1153 / 1155 |
skin | 100% | 17719.24 | 1809 / 1809 | 100% | 146.67 | 471 / 472 |
uterus | 100% | 18124.79 | 170 / 170 | 100% | 139.02 | 458 / 459 |
bladder | 100% | 15218.57 | 21 / 21 | 100% | 119.24 | 502 / 504 |
thymus | 100% | 16029.93 | 653 / 653 | 100% | 111.33 | 602 / 605 |
pancreas | 100% | 13083.49 | 328 / 328 | 99% | 89.18 | 177 / 178 |
brain | 99% | 8785.36 | 2625 / 2642 | 100% | 121.05 | 705 / 705 |
adrenal gland | 100% | 20669.05 | 258 / 258 | 99% | 78.04 | 227 / 230 |
liver | 100% | 8393.50 | 226 / 226 | 99% | 75.18 | 400 / 406 |
kidney | 100% | 12195.15 | 89 / 89 | 98% | 77.45 | 884 / 901 |
adipose | 100% | 15378.53 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 14802.92 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 115.58 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 129.51 | 29 / 29 |
spleen | 100% | 16573.06 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 121.29 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 51.60 | 1 / 1 |
muscle | 100% | 8135.73 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 97% | 7520.22 | 838 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 12791.81 | 903 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006281 | Biological process | DNA repair |
GO_0006397 | Biological process | mRNA processing |
GO_1903377 | Biological process | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway |
GO_0045087 | Biological process | innate immune response |
GO_0007623 | Biological process | circadian rhythm |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_0008380 | Biological process | RNA splicing |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0002218 | Biological process | activation of innate immune response |
GO_0006310 | Biological process | DNA recombination |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0016020 | Cellular component | membrane |
GO_0016607 | Cellular component | nuclear speck |
GO_0005654 | Cellular component | nucleoplasm |
GO_0001650 | Cellular component | fibrillar center |
GO_0016363 | Cellular component | nuclear matrix |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0042382 | Cellular component | paraspeckles |
GO_0005694 | Cellular component | chromosome |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0003682 | Molecular function | chromatin binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0003723 | Molecular function | RNA binding |
GO_0005515 | Molecular function | protein binding |
Gene name | NONO |
Protein name | Non-POU domain-containing octamer-binding protein Non-POU domain containing octamer binding Non-POU domain containing octamer-binding isoform 1 Non-POU domain containing octamer-binding isoform 2 Non-POU domain-containing octamer-binding protein (NonO protein) (54 kDa nuclear RNA- and DNA-binding protein) (p54(nrb)) (p54nrb) (55 kDa nuclear protein) (NMT55) (DNA-binding p52/p100 complex, 52 kDa subunit) |
Synonyms | NRB54 |
Description | FUNCTION: DNA- and RNA binding protein, involved in several nuclear processes . Binds the conventional octamer sequence in double-stranded DNA . Also binds single-stranded DNA and RNA at a site independent of the duplex site . Involved in pre-mRNA splicing, probably as a heterodimer with SFPQ . Interacts with U5 snRNA, probably by binding to a purine-rich sequence located on the 3' side of U5 snRNA stem 1b . Together with PSPC1, required for the formation of nuclear paraspeckles . The SFPQ-NONO heteromer associated with MATR3 may play a role in nuclear retention of defective RNAs . The SFPQ-NONO heteromer may be involved in DNA unwinding by modulating the function of topoisomerase I/TOP1 . The SFPQ-NONO heteromer may be involved in DNA non-homologous end joining (NHEJ) required for double-strand break repair and V(D)J recombination and may stabilize paired DNA ends . In vitro, the complex strongly stimulates DNA end joining, binds directly to the DNA substrates and cooperates with the Ku70/G22P1-Ku80/XRCC5 (Ku) dimer to establish a functional preligation complex . NONO is involved in transcriptional regulation. The SFPQ-NONO-NR5A1 complex binds to the CYP17 promoter and regulates basal and cAMP-dependent transcriptional activity . NONO binds to an enhancer element in long terminal repeats of endogenous intracisternal A particles (IAPs) and activates transcription (By similarity). Regulates the circadian clock by repressing the transcriptional activator activity of the CLOCK-BMAL1 heterodimer (By similarity). Important for the functional organization of GABAergic synapses (By similarity). Plays a specific and important role in the regulation of synaptic RNAs and GPHN/gephyrin scaffold structure, through the regulation of GABRA2 transcript (By similarity). Plays a key role during neuronal differentiation by recruiting TET1 to genomic loci and thereby regulating 5-hydroxymethylcytosine levels (By similarity). Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway . Promotes activation of the cGAS-STING pathway in response to HIV-2 infection: acts by interacting with HIV-2 Capsid protein p24, thereby promoting detection of viral DNA by CGAS, leading to CGAS-mediated inmmune activation . In contrast, the weak interaction with HIV-1 Capsid protein p24 does not allow activation of the cGAS-STING pathway . . |
Accessions | ENST00000677014.1 ENST00000677245.1 ENST00000678335.1 ENST00000450092.6 [Q15233-1] ENST00000678231.1 [Q15233-1] ENST00000450092 ENST00000677879.1 ENST00000677446.1 [Q15233-1] ENST00000676797.1 [Q15233-2] ENST00000678830.1 ENST00000276079.13 [Q15233-1] C9IZL7 ENST00000420903 C9JYS8 ENST00000454976 C9J4X2 A0A7I2V5Y7 Q15233 ENST00000679029.1 A0A7I2V4N2 C9JJ13 ENST00000678660.1 ENST00000413858.5 A0A0S2Z4Z9 A0A7I2V464 ENST00000677274.1 [Q15233-1] A0A0S2Z4E7 A0A7I2V447 H7C367 ENST00000677612.1 [Q15233-1] ENST00000535149.5 [Q15233-2] ENST00000418921.1 ENST00000373856.8 A0A7P0MRW0 ENST00000420903.6 [Q15233-1] ENST00000373841.5 [Q15233-1] A0A7I2V535 A0A7I2YQK8 ENST00000454976.2 [Q15233-1] A0A7I2V4K9 A0A7I2V4J2 ENST00000678437.1 |